Vera Therapeutics Inc. Class A (VERA) Financials

$33.78

$-1.50 (-4.25%)

As on 09-Sep-2026 16:10EDT

Market cap

$2,586 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

6.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	1.86	--	--
Cost of Revenue	-0.31	0.47	2.17	-1.86	-0.85	0.18
Gross Profit	0.31	-0.47	-2.17	1.86	0.85	-0.18
Operating Expenses	416.89	315.47	167.17	102.01	90.90	34.40
Operating Profit (EBIT)	-415.76	-315.47	-167.17	-102.01	-90.90	-34.40
Other Income	--	--	--	--	-2.84	1.81
Profit before Tax	-401.90	-299.61	-152.15	-95.99	-89.06	-32.61
Provision for Tax	0.00	0.00	0.00	0.00	0.00	0.00
Profit after Tax (Net Income)	-401.90	-299.62	-152.15	-95.99	-89.06	-32.61
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	89.06	-32.61

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	407.76	604.52	577.16	101.69	76.91	69.59
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	76.91	76.76	53.16	51.56	28.93	6.47
Current Liabilities	48.32	53.46	25.37	22.30	25.60	7.69
Total Liabilities	581.31	734.73	655.68	175.55	131.44	83.75

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	5.49	5.85	4.46	3.52	5.74	1.21
Current Assets	527.49	728.88	651.22	172.02	125.70	82.54
Total Assets	581.31	734.73	655.68	175.55	131.44	83.75
Total Debt*	75.23	77.31	54.64	53.71	31.29	4.92
Net Current Assets	479.17	675.43	625.85	149.72	100.10	74.85

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-241.10	-134.68	-92.18	-67.60	-23.71
Cash Flow from Investing Activities	--	194.29	-425.03	-39.43	-70.55	-4.20
Cash from Financing Activities	--	308.90	606.67	133.54	101.93	53.88
Net Cash Inflow / Outflow	--	--	--	--	-36.22	25.97

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-5.89	-4.66	-2.77	-2.16	-3.20	-1.53
Cash EPS ($)	--	-4.66	-2.77	-2.24	-3.23	-1.52
Adjusted Book Value ($)	--	9.41	10.51	2.29	2.77	3.27
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-3.75	-2.45	-2.07	-2.43	-1.11
Free Cash Flow per Share ($)	--	-3.76	-2.47	-2.08	-2.43	-1.11

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-45.62	-38.66	-72.83	-97.48	439.74
ROE (%)	-79.40	-50.71	-44.83	-107.50	-121.58	330.12
ROA (%)	-67.35	-43.10	-36.61	-62.54	-82.77	-47.16
EBIT Margin (%)	--	--	--	-4,951.83	--	--
Net Margin (%)	--	--	--	-5,155.21	3,135.77	-1,797.63
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	-1.00	--	--	--
EBIT Growth (%)	-85.31	-102.10	-56.74	-1.43	-164.24	35.39
Net Profit Growth (%)	-84.12	-96.92	-58.50	-7.79	-173.10	38.95
EPS Growth (%)	-61.36	-0.68	-0.28	0.33	-1.09	0.41
Book Value Growth (%)	-22.68	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-10.86	-15.26	-7.12	-6.04	-17.43
Price / Book Value	6.06	5.38	4.02	6.72	6.99	8.17
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-3.60	-8.97	-12.02	-6.26	-4.95	-14.40
Close Price ($)	42.91	50.64	42.29	15.38	19.35	26.72
High Price ($)	56.05	56.05	51.61	20.23	29.20	37.11
Low Price ($)	19.07	18.53	14.20	5.20	12.29	11.30
Market Cap ($ Cr)	2,586.35	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.18	0.13	0.09	0.53	0.41	0.07
Short term debt to equity ratio	--	0.00	0.00	0.02	0.03	--
Current Ratio	10.92	13.64	25.67	7.71	4.91	10.73
Quick Ratio	10.92	--	--	--	--	--
Interest Coverage	-34.70	-38.78	-18.95	-24.35	-91.64	-1,720.10

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	0.01	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	979.53
Payable days	--	11,536.20	1,581.49	-2,266.53	-2,887.46	2,380.35
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.